Legato Capital Management LLC Cuts Position in Mirion Technologies, Inc. (NYSE:MIR)

Legato Capital Management LLC decreased its position in shares of Mirion Technologies, Inc. (NYSE:MIR) by 20.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 145,470 shares of the company’s stock after selling 36,498 shares during the period. Legato Capital Management LLC owned approximately 0.06% of Mirion Technologies worth $2,538,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. KBC Group NV boosted its stake in shares of Mirion Technologies by 39.2% in the 4th quarter. KBC Group NV now owns 8,002 shares of the company’s stock valued at $140,000 after purchasing an additional 2,254 shares in the last quarter. Oppenheimer & Co. Inc. boosted its position in Mirion Technologies by 4.7% during the third quarter. Oppenheimer & Co. Inc. now owns 58,260 shares of the company’s stock valued at $645,000 after buying an additional 2,595 shares during the period. Royce & Associates LP grew its stake in shares of Mirion Technologies by 0.8% during the third quarter. Royce & Associates LP now owns 484,000 shares of the company’s stock valued at $5,358,000 after buying an additional 4,000 shares during the last quarter. State of New Jersey Common Pension Fund D increased its holdings in shares of Mirion Technologies by 2.3% in the third quarter. State of New Jersey Common Pension Fund D now owns 179,998 shares of the company’s stock worth $1,993,000 after buying an additional 4,043 shares during the period. Finally, Quest Partners LLC lifted its stake in shares of Mirion Technologies by 680.5% in the 3rd quarter. Quest Partners LLC now owns 6,728 shares of the company’s stock valued at $74,000 after acquiring an additional 5,866 shares during the last quarter. Hedge funds and other institutional investors own 78.51% of the company’s stock.

Mirion Technologies Price Performance

Shares of Mirion Technologies stock opened at $16.16 on Wednesday. The business has a 50 day moving average of $17.02 and a 200 day moving average of $14.03. Mirion Technologies, Inc. has a 52 week low of $9.11 and a 52 week high of $18.81. The company has a market cap of $3.75 billion, a PE ratio of -47.51 and a beta of 0.73. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43.

Mirion Technologies (NYSE:MIR) last issued its quarterly earnings data on Tuesday, February 11th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.14 by $0.02. Mirion Technologies had a negative net margin of 7.84% and a positive return on equity of 4.33%. As a group, equities research analysts forecast that Mirion Technologies, Inc. will post 0.33 earnings per share for the current year.

Wall Street Analysts Forecast Growth

MIR has been the topic of several recent research reports. Citigroup raised their price target on Mirion Technologies from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, December 4th. Robert W. Baird assumed coverage on shares of Mirion Technologies in a report on Thursday, December 19th. They issued an “outperform” rating and a $22.00 target price on the stock. Baird R W raised shares of Mirion Technologies to a “strong-buy” rating in a research note on Thursday, December 19th. Finally, The Goldman Sachs Group increased their price target on shares of Mirion Technologies from $16.00 to $21.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Three analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $19.25.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.